We are shifting perceptions to see waste as a potential resource with a target to have all our waste repurposed for beneficial use by 2030.
Instead of waste streams going to landfill, we seem them as a resource that can be diverted to other uses – helping us to achieve our new goal to repurpose all our waste for beneficial use by 2030. This is because, as well as environmental benefits, there are considerable economic and social benefits to be gained, too.
Today, around 77% of our waste is either recycled or incinerated to generate energy. For example, more than 1.5 million used inhalers have been recycled through our Complete the Cycle programme in the UK since it began in 2012. This has the benefit of avoiding harmful environmental impacts from landfill, as well as keeping materials, such as solvents, in circulation for use in new products. Over 70% of GSK sites and offices have achieved zero waste to landfill, and we are aiming to achieve zero waste to landfill by 2020 at all of our sites.
Read more about waste and recycling
Complete the cycle – how we’re recycling inhalers
When we analysed our carbon footprint in 2010, two things became clear: we needed to take action to reduce it.
'Rightsizing' our tablet packaging to reduce carbon emissions
How can you fit six tablets into the same space as four – and why would you want to?
Find out more
We are working to reduce emissions from our entire value chain while extending access to our products for the people who need them
By better understanding our water use across the value chain, we can focus our efforts where we can make the biggest difference
We are taking steps to ensure that raw materials, such as wood-based packaging materials and palm oil are sourced responsibly.
Responsibility reports & data
Find out about our responsible business performance in our Responsible Business Supplement and other historical resources